Objective: Retrograde intrarenal surgery (RIRS) involves a minimally invasive stone surgery, lending itself potential to combined spinal-epidural anesthesia (CSEA), although it is performed preferably under general anesthesia (GA). This prospective randomized study was undertaken to evaluate the feasibility and efficacy of CSEA for patients undergoing RIRS. Patients and Methods: Seventy consecutive patients who were scheduled for RIRS were randomized to receive CSEA (n = 35) or GA (n = 35). Operative time, stone clearance rate, visual analog scale (VAS) of pain, complication rate, anesthetic cost, and hospital stay were compared between the two groups. Results: A total of 65 patients randomized to CSEA (31) or GA (34) completed the study. In the CSEA group, each procedure was completed and there was no anesthetic conversion. Although based on the prospective randomized method, the GA group still had a little larger stone size ( p = 0.059) and more multiple caliceal stones ( p = 0.037). Overall, there were no statistically significant differences in operative time ( p = 0.088), stone fragmentation time ( p = 0.074), postoperative VAS pain score at 6 and 24 hours ( p = 0.156, 0.146), incidence of complications ( p = 0.870), stone-free rate ( p = 0.804), and hospital stays ( p = 0.907) between the two groups. The patients in the GA group experienced a higher mean hemoglobin drop (6.5 -3.2 vs 8.6 -2.7 g/L, p = 0.012). In addition, the anesthetic cost was much cheaper in the CSEA group (183.8 -31.4 vs 391.9 -59
A single bolus propofol depressed TwPdi evoked by cervical magnetic stimulation, demonstrating inhibitory effects of propofol on diaphragmatic contractility in patients during general anaesthesia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.